+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Toviaz"

Toviaz - API Insight, 2022 - Product Thumbnail Image

Toviaz - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Toviaz- Drug Insight, 2019 - Product Thumbnail Image

Toviaz- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Toviaz is a brand of urological disorder drugs used to treat overactive bladder (OAB). It is a type of antimuscarinic drug, which works by blocking certain nerve signals that cause bladder contractions. Toviaz is used to reduce the number of sudden, strong urges to urinate, as well as the number of times a person needs to urinate during the day and night. It is also used to reduce leakage of urine, which can occur with OAB. Toviaz is available in both immediate-release and extended-release tablets. The extended-release tablets are designed to provide a steady level of medication throughout the day. Common side effects of Toviaz include dry mouth, constipation, and blurred vision. The Toviaz market is composed of several companies that manufacture and distribute the drug. These include Pfizer, Inc., Mylan N.V., and Teva Pharmaceutical Industries Ltd. Show Less Read more